3 Asian Penny Stocks With Market Caps Up To US$900M

As Asian markets navigate a complex landscape marked by fluctuating oil prices and evolving economic policies, investors are increasingly looking beyond traditional blue-chip stocks for opportunities. Penny stocks, often representing smaller or newer companies, continue to capture attention despite their somewhat outdated label. These stocks can offer unique growth potential at lower price points, particularly when backed by strong financials and sound fundamentals.

Let's uncover some gems from our specialized screener.

Goodbaby International Holdings (SEHK:1086)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Goodbaby International Holdings Limited is an investment holding company involved in the design, R&D, manufacturing, marketing, and distribution of children's products across various global markets with a market cap of HK$1.82 billion.

Operations: Revenue segments for this company are not reported.

Market Cap: HK$1.82B

Goodbaby International Holdings has demonstrated robust financial performance, with recent earnings showing a net income increase to HK$275.2 million for the half year ended June 30, 2026, compared to HK$105.39 million a year ago. The company's short-term assets of HK$4.4 billion comfortably cover both short and long-term liabilities, and its debt is well covered by operating cash flow. While Goodbaby's management team is relatively inexperienced with an average tenure of 1.8 years, the board remains seasoned at 9.6 years on average. Despite low return on equity at 5.9%, earnings growth has been strong over the past year at 40.8%.

• Dive into the specifics of Goodbaby International Holdings here with our thorough balance sheet health report.
• Review our growth performance report to gain insights into Goodbaby International Holdings' future.

Kaiser (China) Culture (SZSE:002425)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Kaiser (China) Culture Co., LTD operates in the internet entertainment industry with a market capitalization of approximately CN¥3.44 billion.

Operations: There are no specific revenue segments reported for this company.

Market Cap: CN¥3.44B

Kaiser (China) Culture has shown some improvement, reporting a net income of CN¥4.99 million for the half year ended June 30, 2026, compared to a net loss previously. While unprofitable over the past five years with losses growing annually by 26.8%, the company maintains a strong cash position exceeding its total debt and covering liabilities comfortably. The board and management are experienced with average tenures of 6.8 and 8.5 years respectively, providing stability amid volatility in earnings growth compared to industry benchmarks. Despite challenges, Kaiser retains sufficient cash runway for over three years based on current free cash flow levels.

• Navigate through the intricacies of Kaiser (China) Culture with our comprehensive balance sheet health report here.
• Understand Kaiser (China) Culture's track record by examining our performance history report.

Rastar Group (SZSE:300043)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Rastar Group operates in the game and toy industry in China, with a market cap of CN¥5.87 billion.

Operations: There are no specific revenue segments reported for the company.

Market Cap: CN¥5.87B

Rastar Group, operating in the game and toy industry in China, has recently reported a decline in sales to CN¥517.19 million for the first half of 2026 compared to CN¥1.14 billion a year ago, with net income also decreasing to CN¥92.47 million from CN¥155.05 million. Despite this, Rastar's debt is well-covered by operating cash flow and its net debt to equity ratio is satisfactory at 31.6%. The company has become profitable over the past five years with earnings growth averaging 43.3% annually, supported by an experienced management team and board of directors with average tenures of 3.3 and 4.8 years respectively.

• Click here to discover the nuances of Rastar Group with our detailed analytical financial health report.
• Review our historical performance report to gain insights into Rastar Group's track record.

Where To Now?

• Embark on your investment journey to our 1,039 Asian Penny Stocks selection here.
• Curious About Other Options? AI is about to change healthcare. These 129 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com